Evidence-Based Medicine Guidelines
Certolizumab pegol for rheumatoid arthritis in adults
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Certolizumab Pegol for Rheumatoid Arthritis in Adults." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults.
Certolizumab pegol for rheumatoid arthritis in adults. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults. Accessed October 4, 2023.
Certolizumab pegol for rheumatoid arthritis in adults. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults
Certolizumab Pegol for Rheumatoid Arthritis in Adults [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 October 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Certolizumab pegol for rheumatoid arthritis in adults
ID - 457299
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/457299/all/Certolizumab_pegol_for_rheumatoid_arthritis_in_adults
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
